09-09-2022 16:00-17:00 Track 2

Invited Session

Topic: Glaucoma

Angle Closure Glaucomas: classic and new concepts

Chair(s): Clement Tham (Hong Kong, China); Catherine Jui-ling Liu (Taiwan, China);

Primary Angle-closure Glaucoma How Frequent Is It?
Paul Foster (United Kingdom)
Anterior segment imaging in angle closure: is there anything new?
Benjamin Xu (United States)
My patient has angle closure: which mechanism is going on?
Kyung Rim Sung (South Korea)
Lessons from the ZAP trial: when shall we use an LPI?
David Friedman (United States)
Lessons from the EAGLE trial: is lens extraction a solution?
Augusto Azuara-Blanco (United Kingdom)
Surgical treatment of angle closure
Clement Tham (Hong Kong, China)

12-09-2022 18:30-19:30 Track 1

Invited Session

Topic: Glaucoma

Comprehensive approach to glaucoma care

Chair(s): Ingrida Januleviciene (Lithuania); Tin Aung (Singapore);

How to detect genetic associations in a patient
Tin Aung (Singapore)
What are the most useful biomarkers?
Franz Grus (Germany)
Targeting systemic factors and lifestyle
Ingrida Januleviciene (Lithuania)
Health and Economic Burden of Glaucoma
Anja Tuulonen (Finland)
Glaucoma and Real World Disability
Pradeep Ramulu (United States)

10-09-2022 12:15-13:15 Track 2

Invited Session

Topic: Glaucoma

Lessons from big glaucoma studies

Chair(s): Fabian Lerner (Argentina); Tanuj Dada (India);

Beijing eye study
Ya Xing Wang (People's Republic of China)
Blue Mountains Eye Study
Paul Healey (Australia)
Korea National Health and Nutrition Examination Survey (KNHANES)
Chungkwon Yoo (South Korea)
The first glaucoma SLT trial conducted in Africa (SLT vs. Medication)
Heiko Philippin (United Kingdom)

09-09-2022 21:00-22:00 Track 2

Invited Session

Topic: Glaucoma

Normal Tension Glaucomas: classic and new concepts

Chair(s): Ki Ho Park (South Korea); Jost Jonas (Germany);

Is NTG different from POAG?
Toru Nakazawa (Japan)
Risk factors for NTG.
Ki Ho Park (South Korea)
The potential role of CSFP in the pathophysiology of NTG.
Jost Jonas (Germany)
Should NTG be treated differently?
Dexter Leung (Hong Kong, China)
Surgical considerations when operating on NTG patients
Tetsuya Yamamoto (Japan)

09-09-2022 11:00-12:00 Track 2

Invited Session

Topic: Glaucoma

Open Angle Glaucomas: classic and new concepts

Chair(s): Neeru Gupta (Canada); Ningli Wang (People's Republic of China);

Update on pathophysiology of POAG.
Makoto Aihara (Japan)
Artificial Intelligence for the diagnosis of glaucoma.
Felipe Medeiros (United States)
Update on OCT to diagnose and assess glaucoma progression.
Chris Leung (Hong Kong, China)
When do we start glaucoma treatment: new concepts for pre-perimetric glaucoma?
Fabian Lerner (Argentina)
Aqueous humor regulation - 21 century new concept
Chen Xin (People's Republic of China)

10-09-2022 17:15-18:15 Track 1

Invited Session

Topic: Glaucoma

Surgical Treatment of glaucoma: Current and future

Chair(s): Tanuj Dada (India); Tarek Shaarawy (Switzerland);

New angle based glaucoma surgeries – safety and outcomes
Malik Kahook (United States)
Tips to minimize complications in traditional and new tube-based glaucoma surgeries
Prin Rojanapongpun (Thailand)
Angle Closure Management - A Logical Approach Based on Angle Closure Type and Mechanisms
Clement Tham (Hong Kong, China)
Surgical Treatment of glaucoma: Current and future
Tarek Shaarawy (Switzerland)
Discussion

11-09-2022 14:45-15:45 Track 1

Invited Session

Topic: Glaucoma

Update on glaucoma diagnosis in practice

Chair(s): Jin Wook Jeoung (South Korea); Joel Schuman (United States);

Comparison of different OCT instruments
Joel Schuman (United States)
Optical Coherence Tomograph (OCT) Progression Analysis
Jin Wook Jeoung (South Korea)
C10-2 and macular OCT in glaucoma
Marcelo Nicolela (Canada)
The current role of Optical Coherence Tomography Angiography (OCTA)
Sasan Moghimi (United States)
How can deep learning be applied to our clinical practice?
Michael Girard (Singapore)

09-09-2022 10:00-23:00 Virtual

ICO Member Society: Association of Ophthalmologists of Latvia

Topic: Glaucoma

Association of Ophthalmologists of Latvia session

Chair(s): Juris Vanags (Latvia); Kristine Baumane (Latvia);

Severe ocular trauma characteristics 2 years before COVID-19 pandemic and during the pandemic in Riga Stradins university hospital
Juris Vanags (Latvia)
Penetrating keratoplasty challenging cases.
Ä’riks Elksnis (Latvia)
Lessons learned about Primary Congenital Glaucoma in the Latvian population.
Eva Drucka (Latvia)
DEMEK- results in Latvia
Ilze Šveiduka (Latvia)
The use of ExPress shunt in glaucoma management.
Kristine Baumane (Latvia)
Different approaches to the treatment of dislocated IOLs.
Līga Radecka (Latvia)

09-09-2022 10:00-23:00 Virtual

ICO Member Society: Glaucoma section of the German Ophthalmological Society

Topic: Glaucoma

Glaucoma 2022- from basics to clinic

Chair(s): Esther Hoffmann (Germany);

The Icare-Pro Rebound Tonometer Versus The Hand-held Tonometer in Childhood Glaucoma under Standardized General Anaesthesia - the EyeBIS study.'
Alicja Strzalkowska (Germany)
Mechanisms of fibroid after filtration surgery
Jan Lübke (Germany)
Immune-mediated cell death mechanisms in glaucoma
Stephanie Joachim (Germany)

09-09-2022 19:45-20:45 Track 2

ICO Member Society: World Glaucoma Association

Topic: Glaucoma

Hot Topics in Glaucoma

Chair(s): Tanuj Dada (India); Shan Lin (United States); Anja Tuulonen (Finland);

Current Role of Genetic testing for Glaucoma
Janey Wiggs (United States)
24 Hour IOP Monitoring
Arthur Sit (United States)
Role of OCT Angiography in Glaucoma Diagnosis
Sasan Moghimi (United States)
Myopia and Glaucoma
Ki Ho Park (South Korea)
Aqueous Angiography Guided Glaucoma Surgery
Tanuj Dada (India)

09-09-2022 12:15-13:15 Track 2

ICO Member Society: European Glaucoma Society

Topic: Glaucoma

Treats from the EGS congress in Athens 2022

Chair(s): Luis Abegao Pinto (Portugal); Ananth Viswanathan (United Kingdom);

Will genotyping change our everyday practice in the future?
Ananth Viswanathan (United Kingdom)
Can neuroregeneration reverse glaucoma?
Keith Martin (United Kingdom)
The new EGS Guidelines on Surgical innovation
Luis Abegao Pinto (Portugal)
Timing of surgery: are we fiddling while Rome burns
Stylianos Kandarakis (Greece)
The new EGS Patient Project: communication with the patient
Stelios Georgoulas (United Kingdom)

09-09-2022 10:00-23:00 Virtual

On-Demand

Topic: Glaucoma

Glaucoma Free Paper Session II

Chair(s): ;

A short online course successfully trains non-ophthalmic graders to recognize glaucomatous optic nerves in low resource settings
Olusola Olawoye (Nigeria)
Comparison of Longitudinal Peripapillary Vessel Density Loss between Normal-Tension Glaucoma and Primary Angle-Closure Glaucoma
Ru Yue Shen (Hong Kong, China)
Endogenous Dual Stimuli-activated NO Generation In the Conventional Outﬂow Pathway for Precision Glaucoma Therapy
TBA
Vitamin A alleviates retinal ganglion cell degeneration via the activation of RARb-ADAM10 axis in a chronic glaucoma mice model
Tianmin Ren (People's Republic of China)
Evaluation of Genetic Markers of LOXL1 and CACNA1A and Their Association with Pseudoexfoliation Disease in Malays
Muhammad Ikmal Mohamad (Malaysia)
Targeting the AhR with ITE limit NF-κB dependent microglia inflammation and neurodegeneration in acute ocular hypertension injury
Yijie Yang (People's Republic of China)

09-09-2022 10:00-23:00 Virtual

On-Demand

Topic: Glaucoma

Glaucoma Free Paper Session III

Chair(s): ;

Structure-function agreement in glaucoma progression: visual field testing, disc photography, RNFL and neuroretinal rim thickness
Dhruv Manik (United States)
Bleb-less glaucoma surgery to activate uveolymphatic route of aqueous humor outflow in management of glaucoma in cataract patients
Vinod Kumar (Russian Federation)
Accurate External Localization of Schlemm’s Canal and Relative Parameters Measurement in Patients with Primary Open-angle Glaucoma
Junjie Peng (People's Republic of China)
Omidenepag Isopropyl 0.002% Significantly Lowers IOP in Latanoprost Low/Non-Responders with POAG or OHT: Phase 3 SPECTRUM 5 study
Eugene B. McLaurin (United States)
Tafluprost promotes axon regeneration after optic nerve crush via the Zn2+/mTOR pathway
TBA
Melatonin Prevents Acute Ocular Hypertension-Induced Oxidative Stress, Senescence, and Inflammation in Anterior Segment of Mice
Dan Ye (People's Republic of China)